Facet browsing currently unavailable
Page 5 of 181 results
Sort by: relevance publication year
<p>A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity</p> JOURNAL ARTICLE published October 2020 in Lung Cancer: Targets and Therapy |
Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy JOURNAL ARTICLE published September 2022 in Lung Cancer: Targets and Therapy |
<p>Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer</p> JOURNAL ARTICLE published December 2019 in Lung Cancer: Targets and Therapy |
<p>TKI-resistant <em>ALK</em>-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations</p> JOURNAL ARTICLE published August 2019 in Lung Cancer: Targets and Therapy |
<p>Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer</p> JOURNAL ARTICLE published June 2019 in Lung Cancer: Targets and Therapy |
Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study JOURNAL ARTICLE published November 2012 in Lung Cancer: Targets and Therapy |
Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer JOURNAL ARTICLE published January 2015 in Lung Cancer: Targets and Therapy |
1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT JOURNAL ARTICLE published August 2018 in Lung Cancer: Targets and Therapy |
CodeBreaK 200: Sotorasib (AMG510) Has Broken the KRAS G12C+ NSCLC Enigma Code JOURNAL ARTICLE published April 2023 in Lung Cancer: Targets and Therapy |
From ASCEND-5 to ALUR to ALTA-3, an Anti-Climactic End to the Era of Randomized Phase 3 Trials of Next-Generation ALK TKIs in the Crizotinib-Refractory Setting JOURNAL ARTICLE published June 2023 in Lung Cancer: Targets and Therapy |
Prevalence of driver mutations in non-small-cell lung cancers in the People’s Republic of China JOURNAL ARTICLE published February 2014 in Lung Cancer: Targets and Therapy |
Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study JOURNAL ARTICLE published March 2024 in Lung Cancer: Targets and Therapy |
Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer JOURNAL ARTICLE published December 2021 in Lung Cancer: Targets and Therapy |
Innovative Techniques in Video-Assisted Thoracoscopic Surgery: Lu’s Approach JOURNAL ARTICLE published February 2024 in Lung Cancer: Targets and Therapy |
<em>EGFR</em> T790M: revealing the secrets of a gatekeeper JOURNAL ARTICLE published October 2017 in Lung Cancer: Targets and Therapy |
Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer JOURNAL ARTICLE published June 2021 in Lung Cancer: Targets and Therapy |
Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy JOURNAL ARTICLE published August 2017 in Lung Cancer: Targets and Therapy |
Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes JOURNAL ARTICLE published August 2018 in Lung Cancer: Targets and Therapy |
Lung cancer in Brazil: epidemiology and treatment challenges JOURNAL ARTICLE published November 2016 in Lung Cancer: Targets and Therapy |
Maintenance therapy for metastatic non-small-cell lung cancer – the role of pemetrexed JOURNAL ARTICLE published April 2010 in Lung Cancer: Targets and Therapy |